64406-022 : Tofidence 20 mg/ml Intravenous Injection
| NDC: | 64406-022 |
| Labeler: | Biogen Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: | Tofidence |
| Dosage Form: | Intravenous Injection |
| Application #: | BLA761354 |
| Rev. Date: |
NDC Package Codes:
- 64406-022-01: 1 VIAL, SINGLE‑USE IN 1 CARTON (64406‑022‑01) / 4 ML IN 1 VIAL, SINGLE‑USE
Active Ingredients:
- Tocilizumab
Dosage Strength:
- 20 mg/mL
Pharmaceutical Classes:
- Interleukin 6 Receptor Antagonists [MoA]
- Interleukin-6 Receptor Antagonist [EPC]
Related Products:
Based on records with the same trade name.- 64406-023 Tofidence 20 mg/ml Intravenous Injection by Biogen Inc.
- 64406-024 Tofidence 20 mg/ml Intravenous Injection by Biogen Inc.
- 78206-200 Tofidence 80 mg/4ml Intravenous Injection by Organon LLC
- 78206-201 Tofidence 200 mg/10ml Intravenous Injection by Organon LLC
- 78206-202 Tofidence 400 mg/20ml Intravenous Injection by Organon LLC
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 64406-020Next: 64406-023 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.